Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $8.8050 (-5.12%) ($8.7850 - $8.8050) on Fri. Jun. 16, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.75% (three month average) | RSI | 52 | Latest Price | $8.8050(-5.12%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.6% a day on average for past five trading days. | Weekly Trend | EDIT advances 3.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(63%) IBB(50%) IWC(47%) IWM(44%) IWO(44%) | Factors Impacting EDIT price | EDIT will decline at least -2.875% in a week (0% probabilities). IGOV(-16%) TBT(-12%) UUP(-7%) UNG(-7%) CEMB(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.875% (StdDev 5.75%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $9.62 | 5 Day Moving Average | $9.83(-10.43%) | 10 Day Moving Average | $9.88(-10.88%) | 20 Day Moving Average | $9.62(-8.47%) | To recent high | -23.4% | To recent low | 38.6% | Market Cap | $547m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |